Canada Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342800
  • Report
  • Region: Canada
  • 165 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • GlaxoSmithKline Plc
  • MORE
Canada Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "Canada Drug Delivery Devices Market Outlook to 2023", provides key market data on the Canada Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Canada Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • GlaxoSmithKline Plc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, Canada
3.1 Drug Delivery Devices Market, Canada, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, Canada, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, Canada, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, Canada, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, Canada, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, Canada
4.1 Central Venous Catheters Market, Canada, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, Canada, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, Canada, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, Canada, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, Canada, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, Canada, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, Canada, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, Canada
5.1 Infusion Systems Market, Canada, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, Canada, Segment Contribution (%), 2016
5.3 Infusion Systems Market, Canada, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, Canada, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, Canada, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, Canada, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, Canada, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, Canada, Volume (Units), 2009-2016
5.6 Infusion Systems Market, Canada, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, Canada, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, Canada, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, Canada, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, Canada, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, Canada, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, Canada, Company Share by Revenue ($m), 2016
6 Infusion Systems Market, Canada
6.1 Needle Free Injections Market, Canada, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, Canada, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, Canada, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, Canada, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, Canada, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, Canada
7.1 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, Canada, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, Canada, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in Canada, Drug Delivery Devices Market
8.1 GlaxoSmithKline Plc
8.1.1 Company Overview
8.2 Hospira Inc
8.2.1 Company Overview
8.3 Becton Dickinson and Co
8.3.1 Company Overview
8.4 AstraZeneca Plc
8.4.1 Company Overview
8.5 Baxter International Inc
8.5.1 Company Overview
8.6 Medtronic Plc
8.6.1 Company Overview
8.7 Boehringer Ingelheim GmbH
8.7.1 Company Overview
8.8 Pfizer Inc
8.8.1 Company Overview
8.9 Merck & Co Inc
8.9.1 Company Overview
8.10 Fresenius Kabi AG
8.10.1 Company Overview
8.11 Glenmark Pharmaceuticals Ltd
8.11.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Acquisition
10.1.1 Teleflex Acquires Pyng Medical
10.2 Asset Transactions
10.2.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.3 Equity Offerings
10.3.1 InMed Pharma Raises USD4.3 Million in Public Offering of Units
10.3.2 Aequus Pharma Raises USD3.9 Million in Public Offering of Units
10.3.3 RepliCel Life Sciences Raises USD2 Million in Private Placement of Units
10.3.4 RepliCel Life Sciences Raises USD0.3 Million in Private Placement of Units
10.3.5 Tetra Bio-Pharma Raises USD0.8 Million in Private Placement of Units
10.3.6 RepliCel Life Sciences Raises USD3.3 Million in Private Placement of Units
10.3.7 Aequus Pharma Raises USD2 Million in Public Offering of Shares
10.4 Partnerships
10.4.1 Vetter Pharma International and Microdermics Enter into Agreement
10.4.2 United Therapeutics Enters into Licensing Agreement with Respira Therapeutics
10.4.3 CannaRoyalty Enters into Licensing Agreement with NuTrae
10.4.4 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.4.5 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.4.6 Hikma Pharma Enters into Licensing Agreement with Orion
10.4.7 Pfizer Terminates its Licensing Agreement with pSivida
10.4.8 Bayer Enters into Licensing Agreement with DelSiTech
10.4.9 BioCorRx Enters into Licensing Agreement with Therakine
10.5 Venture Financing
10.5.1 Microdermics Raises USD1 Million in Venture Financing
10.5.2 Microdermics Secures Venture Funding
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jun 14, 2017: Tetra Bio-Pharma Appoints Aphria CFO, Mr. Carl Merton to the Board of Directors
11.1.2 Jun 01, 2017: Novelion Therapeutics Appoints John J. Orloff, M.D., to Its Board of Directors, Steps Down as EVP, Head of R&D
11.1.3 May 30, 2017: Tetra Bio-Pharma Strengthens its Board with the Appointment of Dr. Bill Cheliak
11.1.4 May 10, 2017: Tetra Bio-Pharma Strengthens Management Team
11.1.5 Apr 24, 2017: Tetra Bio-Pharma Accelerates Sales Strategy with the Appointment of Denis Courchesne as Vice President, Sales
11.1.6 Mar 31, 2017: Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
11.1.7 Mar 27, 2017: Tetra Bio-Pharma Appoints Edward Miller as Vice President, Investor Relations & Corporate Communications
11.1.8 Feb 03, 2017: RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors
11.1.9 Jan 25, 2017: Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology
11.1.10 Nov 16, 2016: Nuvo Pharmaceuticals appoints new president
11.1.11 Nov 16, 2016: Nuvo Pharmaceuticals Appoints Jesse Ledger as President
11.1.12 Sep 01, 2016: Nuvo Pharmaceuticals Appoints New Chief Financial Officer
11.1.13 Jul 22, 2016: Aequus Appoints Ann Fehr as Chief Financial Officer
11.2 Financial Announcements
11.2.1 May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights
11.2.2 May 25, 2017: BioSyent Releases Q1 2017 Results
11.2.3 May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results
11.2.4 May 09, 2017: Novelion Therapeutics Reports First Quarter 2017 Financial Results
11.2.5 May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights
11.2.6 Mar 28, 2017: Intelgenx Reports Fourth Quarter And Full-Year 2016 Financial Results
11.2.7 Mar 15, 2017: Novelion Therapeutics Reports Preliminary Fourth Quarter & Full Year 2016 Financial Results
11.2.8 Mar 15, 2017: BioSyent Releases Results for Fourth Quarter and Full Year 2016
11.2.9 Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results
11.2.10 Feb 28, 2017: Pyng Medical Reports First Quarter Fiscal 2017 Results
11.2.11 Jan 10, 2017: Pyng Medical Reports Fiscal 2016 Financial Results
11.2.12 Jan 09, 2017: Novelion Therapeutics Reports Preliminary 2016 Net Product Sales and Provides 2017 Outlook
11.2.13 Nov 30, 2016: Aequus Provides Q3 2016 Financial Highlights With Substantial Increase in Quarter Over Quarter Revenues
11.2.14 Nov 23, 2016: BioSyent Releases Results for Third Quarter and First Nine Months of 2016
11.2.15 Nov 10, 2016: Nuvo Pharmaceuticals Announces 2016 Third Quarter Results
11.2.16 Nov 01, 2016: QLT Announces Third Quarter 2016 Results
11.2.17 Oct 03, 2016: Proteocyte Diagnostics launches Straticyte to US market at AAOMS Annual Meeting
11.2.18 Aug 23, 2016: Pyng Medical Reports Third Quarter Fiscal 2016 Results
11.2.19 Aug 12, 2016: BioSyent Releases Q2 and H1 2016 Results
11.2.20 Aug 10, 2016: Nuvo Pharmaceuticals Announces 2016 Second Quarter Results
11.2.21 Aug 09, 2016: QLT Announces Second Quarter 2016 Results
11.3 Legal And Regulatory
11.3.1 Apr 19, 2017: Novelion Therapeutics’ Request to Voluntarily Delist from the Toronto Stock Exchange Granted
11.4 Other Significant Developments
11.4.1 Jun 15, 2017: Trudell Medical International: Providing patient-focused solutions and reducing health system costs: our journey in the global fight against COPD
11.4.2 Jun 01, 2017: Aequus Pharmaceuticals and CDRD Announce Research Collaboration to Improve Cannabinoid-Based Therapeutics
11.4.3 Apr 27, 2017: Pendant Biosciences Announces Acceptance into JLABS Toronto
11.4.4 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest
11.4.5 Jan 05, 2017: RepliCel CEO Provides 2017 Forecast
11.4.6 Oct 20, 2016: JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D
11.4.7 Aug 30, 2016: Aequus Provides Corporate Update on Commercial and Development Programs
11.5 Product News
11.5.1 Jul 12, 2017: Intelgenx Presents at BIT's 7th Annual International Symposium of Drug Delivery Systems
11.5.2 Nov 12, 2016: Teleflex nasal spray syringe devices recalled; may fail to deliver full dose of medication
11.6 Strategy And Business Planning
11.6.1 May 25, 2017: RepliCel CEO Provides Company Outlook
11.6.2 Jan 31, 2017: CrossLife Awarded NIH SBIR Grant to Point of Care Detection of Zika virus
11.6.3 Oct 06, 2016: Precision NanoSystems New Headquarters Designed to Enhance Product and Service Offerings to Customers Developing Novel Nanomedicines
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, Canada, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, Canada, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, Canada, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, Canada, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, Canada, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, Canada, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, Canada, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, Canada, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, Canada, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, Canada, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: Teleflex Acquires Pyng Medical
Table 46: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 47: InMed Pharma Raises USD4.3 Million in Public Offering of Units
Table 48: Aequus Pharma Raises USD3.9 Million in Public Offering of Units
Table 49: RepliCel Life Sciences Raises USD2 Million in Private Placement of Units
Table 50: RepliCel Life Sciences Raises USD0.3 Million in Private Placement of Units
Table 51: Tetra Bio-Pharma Raises USD0.8 Million in Private Placement of Units
Table 52: RepliCel Life Sciences Raises USD3.3 Million in Private Placement of Units
Table 53: Aequus Pharma Raises USD2 Million in Public Offering of Shares
Table 54: Vetter Pharma International and Microdermics Enter into Agreement
Table 55: United Therapeutics Enters into Licensing Agreement with Respira Therapeutics
Table 56: CannaRoyalty Enters into Licensing Agreement with NuTrae
Table 57: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 58: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 59: Hikma Pharma Enters into Licensing Agreement with Orion
Table 60: Pfizer Terminates its Licensing Agreement with pSivida
Table 61: Bayer Enters into Licensing Agreement with DelSiTech
Table 62: BioCorRx Enters into Licensing Agreement with Therakine
Table 63: Microdermics Raises USD1 Million in Venture Financing
Table 64: Microdermics Secures Venture Funding

List of Figures
Figure 1: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, Canada, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, Canada, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, Canada, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, Canada, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, Canada, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, Canada, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, Canada, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, Canada, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, Canada, Company Share (%) 2016
Figure 18: Infusion Systems Market, Canada, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, Canada, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, Canada, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, Canada, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, Canada, Company Share (%) 2016
Figure 33: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, Canada, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, Canada, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, Canada, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc
  • Hospira Inc
  • Becton Dickinson and Co
  • AstraZeneca Plc
  • Baxter International Inc
  • Medtronic Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Merck & Co Inc
  • Fresenius Kabi AG
  • Glenmark Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll